Abstract
Purpose
The aim of the study was to detect adverse drug reactions (ADRs) in pediatric inpatients using the medical administrative database “Programme de Médicalisation des Systèmes d′Information” (PMSI) and to compare these cases ADRs with those spontaneously reported to a regional PharmacoVigilance (PV) Centre.
Methods
The study was conducted from January 2008 to December 2011 in the Children University Hospital of Toulouse (Midi-Pyrénées, South-west France). From PMSI database, all discharge summaries including selected ICD-10 codes (10th International Classification of Diseases) were analyzed. All ADRs spontaneously reported by the Children Hospital of Toulouse and registered in the French PV Database (FPVDB) were included. The capture–recapture method was applied to estimate the incidence of ADRs.
Results
During the study period, we identified 60 reports from the PMSI database and 200 from the FPVDB. The rate of “serious” ADRs was higher in PMSI reports (74.6 % vs 38.9 %, p < 0.0001). The most frequent ADRs reported were musculoskeletal (12.4 %) and central (11.3 %) ADRs in PMSI database versus cutaneous (22.4 %) and general (17.5 %) ADRs in FPVDB. The most frequently suspected drugs were antineoplastic drugs (31.1 %) in PMSI database versus anti-infectives (38.2 %) in FPVDB. The estimated number of ADRs was 717 [95 % confidence interval (CI) 513, 921], and the incidence of ADRs among admissions was 0.6 % (95 % CI 0.4, 0.8).
Conclusions
Use of PMSI database improves from around 30 % detection of ADRs in children. In comparison with classical pharmacovigilance database, it also allows to detect different ADRs and drugs, thus enhancing safe medicine use for pediatric patients.
Similar content being viewed by others
References
Aagaard L, Christensen A, Hansen EH (2010) Information about adverse drug reactions reported in children: a qualitative review of empirical studies. Br J Clin Pharmacol 70:481–491
Choonara I (2013) Educational paper: aspects of clinical pharmacology in children (2013) pharmacovigilance and safety. Eur J Pediatr 172:577–580
Gallagher R, Mason J, Bird K, Kirkham J, Peak M, Williamsom P, Nunn A, Turner M, Pirmohamed M, Smyth R (2012) Adverse drug reactions causing admission to a paediatric hospital. PloS One 7:e50127
Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M (2001) Incidence of adverse drug reactions in paediatric in/out patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 52:77–83
Smyth RMD, Gargon E, Kirkham J, Cresswell L, Golder S, Smyth R, Williamson P (2012) Adverse drug reactions in children—a systematic review. PloS One 7:1–24
Johann-Liang R, Wyeth J, Chen M, Cope J (2009) Pediatric drug surveillance and the food and drug administration’s adverse event reporting system: an overview of reports, 2003–2007. Pharmacoepidemiol Drug Saf 18:24–27
Autret-Leca E, Marchand MS, Cissokoa H, Beau-Salinas F, Jonville-Bera AP (2012) Pharmacovigilance in children. Arch Pediatr 19:848–855
Horen B, Montastruc JL, Lapeyre-Mestre M (2002) Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 54(6):665–670
Milne CP, Davis J (2014) The pediatric studies initiative: after 15 years have we reached the limits of the law? Clin Ther 95(1):98–109
Haslund-Krog S, Mathiasen R, Christensen HR, Holst H (2014) The impact of legislation on drug substances used off-label in paediatric wards—a nationwide study. Eur J Clin Pharmacol 70(4):448–452
Aagaard L, Weber CB, Hansen EH (2010) Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf 33:327–339
Miguel A, Azevedo LF, Lopes F, Freitas A et al (2013) Methodologies for the detection of adverse drug reactions: comparison of hospital databases, charts review and spontaneous reporting. Pharmacoepidemiol Drug Saf 22:98–102
Martin-Latry K, Bégaud B (2010) Pharmacoepidemiological research using French reimbursement databases: yes we can! Pharmacoepidemiol Drug Saf 19:256–265
Neubert A, Doormann H, Weiss J, Criegge-Rieck M, Ackermann A, Levy M, Brune K, Rasher W (2006) Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients? Eur J Clin Pharmacol 62:959–965
Neubert A, Sturkenboom MC, Murray ML, Verhamme KM, Nicolosi A, Giaquinto C, Ceci A, Wong IC, TEDDY Network of Excellence (2008) Databases for pediatric medicine research in Europe—assessment and critical appraisal. Pharmacoepidemiol Drug Saf 17:1155–1167
Bates DW, Evans RS, Murff H, Stetson PD, Pizziferri L, Hripcsak G (2003) Detecting adverse events using information technology. J Am Med Inform Assoc 10:115–128
Tavassoli N, Duchayne E, Sadaba B, Desboeuf K, Sommet A, Lapeyre-Mestre M, Muoz MJ, Sie P, Honorato J, Montastruc JL, Bagheri H (2007) Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals. Eur J Clin Pharmacol 63:221–228
Lugardon S, Desboeuf K, Fernet P, Montastruc JL, Lapeyre-Mestre M (2006) Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital. Br J Clin Pharmacol 62:225–231
Begaud B, Evreux JC, Jouglard J, Lagier G (1985) Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 40:111–118
Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356:1255–1259
Gallay A, Nardonnel A, Vaillant V, Desenclos JC (2002) The capture-recapture applied to epidemiology: principles, limits and application. Rev Epidemiol Sante Publique 50:219–232
Weill A, Païta M, Tuppin P, Fagot JP, Neumann A, Simon D, Ricordeau P, Montastruc JL, Allemand H (2010) Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus. Pharmacoepidemiol Drug Saf 19:1256–1262
Couffignal AL, Lapeyre-Mestre M, Bonhomme C, Bugat R, Montastruc JL (2000) Adverse effects of anticancer drugs: a propos of a pharmacovigilance study at a specialized oncology institution. Therapie 55:635–641
Jouanjus E, Leymarie F, Tubery M, Lapeyre-Mestre M (2011) Cannabis-related hospitalizations: unexpected serious events identified through hospital databases. Br J Clin Pharmacol 71:758–765
Jouanjus E, Pourcel L, Saivin S, Molinier L, Lapeyre-Mestre M (2012) Use of multiple sources and capture-recapture method to estimate the frequency of hospitalizations related to drug abuse. Pharmacoepidemiol Drug Saf 21:733–741
Daveluy A, Miremont-Salamé G, Kostrzewa A, Couret A, Lacoin L, Lecomte C, Moore N, Gilleron V, Haramburu F (2012) Identification of abuse and dependence cases through a hospital database. Pharmacoepidemiol Drug Saf 21:1344–1349
Seiber EE (2007) Physician code creep: evidence in Medicaid and State Employee Health Insurance billing. Health Care Financ Rev 28:83–93
Cox AR, Anton C, Goh CHF, Easter M, Langford NJ, Ferner RE (2001) Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. Br J Clin Pharmacol 52:337–339
Lapeyre-Mestre M, Gary J, Machelard-Roumagnac M, Bonhomme C, Bugat R, Montastruc JL (1997) Incidence and cost of adverse drug reactions in a French cancer institute. Eur J Clin Pharmacol 53:19–22
Salmeron-Garcia A, Cabeza Barrera J, Vergara Pavon MJ et al (2012) Detection of adverse drug reactions through the minimum basic data set. Pharm World Sci 32:322–328
Acknowledgments
We would like to thank Charlotte Benzina, Lucie Cantaloube, and Caroline Rossard for data collection.
Conflict of interest
The authors declare that they have no conflict of interest
Author contributions
Dr Durrieu conceptualized and supervised the study, drafted the initial manuscript, and reviewed and revised the manuscript. Dr Batz designed the study and carried out the initial data analysis. Dr Rousseau carried out the final analysis and reviewed the manuscript. Dr Bondon-Guitton contributed to the concept and the design of the study and reviewed the manuscript. Dr Petiot contributed to the concept of the study, extracted data from the administrative hospital database, and reviewed the manuscript. Pr Montastruc reviewed and revised the manuscript. All authors approved the final manuscript as submitted.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Durrieu, G., Batz, A., Rousseau, V. et al. Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital. Eur J Clin Pharmacol 70, 1519–1526 (2014). https://doi.org/10.1007/s00228-014-1763-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-014-1763-1